Report Scope: The scope of this report is broad, covering the applications of CRISPR in medicine, drug therapy and agriculture.The market for CRISPR technology is broken down by application and end user.
Revenue forecasts from 2018-2023 are given for each end user category and application with estimated value derived from the revenue of the companies’ total revenues.
This report also includes a discussion of the major players across each regional market for CRISPR technology with respect to prominent strategic initiatives. Further, it explains the main drivers and regional dynamics of the global market and current trends within the industry.
Report Includes: - 45 data tables and 35 additional tables - An overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline in animal, human and other organisms - Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023 - Explanation of the major drivers and regional dynamics of the global CRISPR market and evaluation of its current market size, and market forecast - Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases - Information on congenital anomalies, its prevalence, causes and its relation to mortality rate - Knowledge about Cell Line Engineering, CRISPR Plasmid, Genetic Engineering, GRNA Database/Gene Library and Human Stem Cells - Insights into regulatory framework and investment analysis - Market share analysis of the leading suppliers of the industry and their detailed company profiles, including Caribou Biosciences, Genscript, Integrated DNA Technologies, Intellia Therapeutics Inc., Precision Biosciences, Sangamo Therapeutics Inc., and Thermo Fisher Scientific
Summary CRISPR is a trending technology that is being widely deployed to edit genes.CRISPR is a simple way of identifying a specific bit of DNA inside a cell and altering it.
CRISPR has also been used to perform other activities, including turning genes on or off without changing sequence.
Although there were ways to edit genes before the introduction of the CRISPR method in 2012, earlier methods took years and cost hundreds of thousands of dollars.CRISPR technology made it cheap and easy for researchers and scientists to carry out gene editing activities.
CRISPR is now used extensively for scientific research.In the foreseeable future, a large number of plants and animals present in farms, gardens and homes will have been altered using CRISPR.
CRISPR derived food is currently in use. CRISPR technology can potentially transform medicine, preventing and curing disease. In China, some use of CRISPR technology has been deemed unethical, but some think that such technology can be of great benefit in the future.
CRISPR is used to create gene drives using fingerprinting cells, logging the functioning and directing the evolution.Cas proteins found in bacteria fight viruses; this is the key to CRISPR.
Cas9 proteins are the most commonly used. With a simple piece of RNA, Cas9 protein can be programmed to find and bind to almost any target sequence desired.
When added to a cell with a piece of guide RNA, CRISPR-Cas9 protein latches on and moves along the strand of DNA to find and bind to a specific, 20-letter-long sequence that matches with part of the guide RNA sequence.
CRISPR/Cas-based gene editing technologies will continue to expand abilities and opportunities in bioscience and drug discovery for researchers in biotechnology and pharmaceutical companies.Existing processes have matured with the help of advanced technology.
Applications such as large, exogenous insertions open exciting possibilities to efficiently model human disease.
Growing incidence of genetic disorders (Melnick-Needles syndrome, down syndrome, cystic fibrosis, Duchenne muscular dystrophy and others) is likely to propel demand for CRISPR technology in the future.According to the World Health Organization (WHO), in 2018, about 10,000 human diseases were reported to be monogenic in nature.
Growing prevalence of genetic diseases stimulates demand for preventive and curative medicines, and is expected to augment the growth of the market for CRISPR technology. Growing demand and technological progression in genome editing, biotechnology, pharmaceuticals, genetic engineering and agriculture will positively influence industry growth in future years.
Our reports have been used by over 10K customers, including:
168 pages •
By Global Industry Analysts
• Apr 2021
- Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Spatial Genomics and Transcriptomics estimated at US$170.7 Million in the year 2020, is projected to reach a revised size of US$275.8 Million by 2027, growing at a CAGR of...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
Spatial Genomics & Transcriptomics Market Report Overview Spatial Genomics & Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Spatial Genomics & Transcriptomics market types and applications. It is a focused study on...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030 Market Report Coverage - Spatial Genomics and Transcriptomics Market Segmentation • Product Type – Kits and Assays, Instruments, Software, and Services • Sample Type – Fresh Frozen Tissues, Fixed Frozen...
178 pages •
By Global Industry Analysts
• Apr 2021
- Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis...
Transcriptomics Market Report Overview Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Transcriptomics market types and applications. It is a focused study on Transcriptomics market space including global and regional...
23andMe, Inc - Tech Innovator Profile
23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.
The report provides information and insights into 23andMe, Inc.’s, including...
This study covers the world outlook for ribonucleic acid (RNA) analysis and transcriptomics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and...
187 pages •
By Global Industry Analysts
• Oct 2019
Transcriptomics market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 13.9%. Microarray, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.